• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

商用散瞳剂对激光闪光细胞测量的影响。

Effect of commercial dilating agents on laser flare-cell measurements.

作者信息

Chin P K, Cuzzani O E, Gimbel H V, Sun R

机构信息

Gimbel Eye Centre, Calgary, Alta.

出版信息

Can J Ophthalmol. 1996 Dec;31(7):362-5.

PMID:8971457
Abstract

OBJECTIVE

To compare the effect of tropicamide alone and tropicamide-phenylephrine on anterior chamber flare and cell measurements obtained with a laser flare-cell meter.

DESIGN

Prospective study.

SETTING

Gimbel Eye Centre, Calgary.

SUBJECTS

Twenty white subjects (10 with blue irides and 10 with brown irides) aged 24 to 45 (mean 30.2) years without any known systemic or ocular disease.

INTERVENTIONS

Laser flare-cell measurements were obtained 30 minutes after pupillary dilation with 1% tropicamide in one eye and a combination drop of 0.8% tropicamide and 5% phenylephrine in the other eye. The average of five readings was taken for each eye.

OUTCOME MEASURES

Flare and cell measurements.

RESULTS

There was no statistically significant difference in flare photon count or cell count between the eyes dilated with tropicamide and those dilated with tropicamide-phenylephrine. In addition, iris colour was not found to have a significant effect on flare and cell measurements.

CONCLUSIONS

Our results suggest that pupillary dilation for laser flare-cell measurements can be done with either mydriatic agent in healthy white subjects of any eye colour without significant effects on the measurements. Further study is needed to determine whether the same is true in older subjects.

摘要

目的

比较单独使用托吡卡胺和托吡卡胺 - 去氧肾上腺素对使用激光闪光细胞仪测量前房闪光和细胞计数的影响。

设计

前瞻性研究。

地点

卡尔加里的金贝尔眼科中心。

受试者

20名白人受试者(10名蓝虹膜和10名棕虹膜),年龄24至45岁(平均30.2岁),无任何已知的全身或眼部疾病。

干预措施

一只眼睛用1%托吡卡胺散瞳30分钟后进行激光闪光细胞测量,另一只眼睛用0.8%托吡卡胺和5%去氧肾上腺素的复方滴眼液散瞳。每只眼睛取五次读数的平均值。

观察指标

闪光和细胞计数。

结果

用托吡卡胺散瞳的眼睛和用托吡卡胺 - 去氧肾上腺素散瞳的眼睛之间,闪光光子计数或细胞计数没有统计学上的显著差异。此外,未发现虹膜颜色对闪光和细胞测量有显著影响。

结论

我们的结果表明,在任何眼色的健康白人受试者中,使用任何一种散瞳剂进行激光闪光细胞测量的散瞳操作,对测量结果均无显著影响。需要进一步研究以确定在老年受试者中是否也是如此。

相似文献

1
Effect of commercial dilating agents on laser flare-cell measurements.商用散瞳剂对激光闪光细胞测量的影响。
Can J Ophthalmol. 1996 Dec;31(7):362-5.
2
A pupillographic evaluation of a phenylephrine HCl 5%-tropicamide 0.8% combination mydriatic.盐酸去氧肾上腺素5%-托吡卡胺0.8%复方散瞳剂的瞳孔描记法评估
J Ocul Pharmacol. 1989 Fall;5(3):199-216. doi: 10.1089/jop.1989.5.199.
3
Comparative pupil dilation using phenylephrine alone or in combination with tropicamide.单独使用去氧肾上腺素或与托吡卡胺联合使用时的瞳孔扩张比较。
Ophthalmology. 1998 Apr;105(4):726-32. doi: 10.1016/S0161-6420(98)94030-1.
4
Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment.2%异波帕胺、10%去氧肾上腺素和1%托吡卡胺对眼前节影响的比较研究
Invest Ophthalmol Vis Sci. 2003 Jan;44(1):281-9. doi: 10.1167/iovs.02-0221.
5
A combination solution for routine pupillary dilation.一种用于常规瞳孔扩张的复方溶液。
Optometry. 2006 Jul;77(7):350-3. doi: 10.1016/j.optm.2006.04.107.
6
Changes in aqueous flare and cells after mydriasis.散瞳后房水闪光和细胞的变化。
Jpn J Ophthalmol. 1989;33(3):271-8.
7
Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.散瞳剂对正常猫眼压和瞳孔大小的影响。
Vet Ophthalmol. 2006 Jul-Aug;9(4):233-7. doi: 10.1111/j.1463-5224.2006.00474.x.
8
[Aqueous flare and cells after mydriasis in normal human eyes].[正常人类眼睛散瞳后的房水闪光和细胞]
Nippon Ganka Gakkai Zasshi. 1989 Jun;93(6):698-704.
9
Comparison of efficacy and tolerance between 1% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) and 0.5% tropicamide combined with 2.5% phenylephrine.1% 羟苯丙胺加 0.25% 托吡卡胺(派立明)与 0.5% 托吡卡胺联合 2.5% 去氧肾上腺素的疗效及耐受性比较。
J Am Optom Assoc. 1996 Nov;67(11):681-9.
10
Efficacy of an eye drop mixture for pupillary dilatation: A randomized comparative study.一种用于瞳孔扩张的滴眼液混合物的疗效:一项随机对照研究。
J Optom. 2017 Apr-Jun;10(2):111-116. doi: 10.1016/j.optom.2016.04.007. Epub 2016 Jun 16.

引用本文的文献

1
Factors influencing aqueous flare after cataract surgery and its evaluation with laser flare photometry.白内障手术后影响房水闪光的因素及其激光闪光光度测定评估
Ther Adv Ophthalmol. 2023 Dec 14;15:25158414231204111. doi: 10.1177/25158414231204111. eCollection 2023 Jan-Dec.
2
The effects of tropicamide and cyclopentolate hydrochloride on laser flare meter measurements in uveitis patients: a comparative study.托吡卡胺和盐酸环喷托酯对葡萄膜炎患者激光闪辉仪测量值的影响:一项对比研究。
Int Ophthalmol. 2021 Mar;41(3):853-857. doi: 10.1007/s10792-020-01639-3. Epub 2020 Nov 16.
3
Long-term stability of uveitis with faint anterior chamber flare treated with once-daily topical ophthalmic betamethasone.
每日一次局部应用倍他米松治疗前房轻度闪辉的葡萄膜炎的长期稳定性。
Inflammation. 2014 Apr;37(2):417-25. doi: 10.1007/s10753-013-9754-4.
4
Quantitative assessment of the effects of pupillary dilation on aqueous flare in eyes with chronic anterior uveitis using laser flare photometry.使用激光散射光度法对慢性前葡萄膜炎患者散瞳对房水闪光的影响进行定量评估。
Int Ophthalmol. 2010 Oct;30(5):491-4. doi: 10.1007/s10792-010-9373-0. Epub 2010 May 26.
5
Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation.激光闪光光度测定法:一种用于测量眼内炎症的非侵入性、客观且定量的方法。
Int Ophthalmol. 2010 Oct;30(5):453-64. doi: 10.1007/s10792-009-9310-2. Epub 2009 May 9.